Adeno‐associated virus (AAV)-based gene therapy for glioblastoma

Glioblastoma (GBM) is the most common and malignant Grade IV primary craniocerebral tumor caused by glial cell carcinogenesis with an extremely poor median survival of 12–18 months. The current standard treatments for GBM, including surgical resection followed by chemotherapy and radiotherapy, fail...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xin, Chen, Wenli, Zhu, Wenjun, Chen, Jing, Ma, Bin, Ding, Jianxia, Wang, Zaichuan, Li, Yifei, Wang, Yeming, Zhang, Xiaochun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836184/
https://www.ncbi.nlm.nih.gov/pubmed/33499886
http://dx.doi.org/10.1186/s12935-021-01776-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836184/
https://www.ncbi.nlm.nih.gov/pubmed/33499886
http://dx.doi.org/10.1186/s12935-021-01776-4

Ejemplares similares